Abstract | PURPOSE: PATIENTS AND METHODS: RESULTS: The outcome of treatment with LDL- apheresis in young patients, using the most recently introduced techniques, is reported. We have submitted to LDL- apheresis 11 pediatric patients. The youngest is aged 3.5. LDL- apheresis is able at improving the metabolic impairment and halting the natural evolution of atherosclerotic disease and atherosclerotic complications. CONCLUSIONS:
|
Authors | C Stefanutti, A Vivenzio, G Lucani, S Di Giacomo |
Journal | La Clinica terapeutica
(Clin Ter)
2001 Jan-Feb
Vol. 152
Issue 1
Pg. 65-9
ISSN: 0009-9074 [Print] Italy |
Vernacular Title | La LDL-Aferesi: stato attuale. |
PMID | 11382172
(Publication Type: English Abstract, Journal Article, Review)
|
Chemical References |
|
Topics |
- Blood Component Removal
- Humans
- Hyperlipoproteinemia Type II
(therapy)
- Lipoproteins, LDL
|